Delhi judges face escalating threats with inadequate security, prompting urgent calls for enhanced protection amid growing ...
Bimekizumab is associated with significant complete clearance rates at 4 years among patients with scalp, nail, or palmoplantar psoriasis.
Background Patients with psoriasis (PsO) are at increased risk of developing psoriatic arthritis (PsA). Emerging evidence ...
Abstract: The ball and beam (BnB) system serves as a benchmark in control engineering as it provides a foundational concept applicable to addressing stabilization challenges of various underactuated ...
The ustekinumab biosimilar AVT04 has consistent efficacy through 28 weeks in patients with PsO with and without prior ustekinumab exposure.
New data from Pearson (FTSE: PSON.L) shows that college students who used AI‑powered adaptive practice questions were more likely to build proficiency than students who used traditional, static ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results